title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Why Is Yellow Trading Higher By 33%: Here Are 48 Stocks Moving Premarket,20220804T105117,https://www.benzinga.com/news/22/08/28349800/why-is-yellow-trading-higher-by-33-here-are-48-stocks-moving-premarket,BNTC,0.059562,Neutral,0.0
"Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday",20220705T083503,https://www.benzinga.com/news/22/07/27948361/accolade-shares-jump-around-29-heres-75-biggest-movers-from-friday,BNTC,0.061758,Neutral,0.001181
"Advanced Human Imaging  ( NASDAQ:AHI ) , Aditxt  ( NASDAQ:ADTX )  - Why Immunocore Shares Dipped 22%; Here Are 73 Biggest Movers From Friday",20220912T072340,https://www.benzinga.com/news/22/09/28823434/why-immunocore-shares-dipped-22-here-are-73-biggest-movers-from-friday,BNTC,0.062597,Somewhat-Bearish,-0.300615
Top 5 NASDAQ Biotech Stocks,20240710T211500,https://investingnews.com/daily/life-science-investing/biotech-investing/top-nasdaq-biotech-stocks/,BNTC,0.035714,Neutral,-0.091127
Stocks That Hit 52-Week Lows On Thursday,20220505T153818,https://www.benzinga.com/markets/options/22/05/27026106/52-weeks-high-and-low-article,BNTC,0.015457,Neutral,-0.007289
"Stocks That Hit 52-Week Lows On Monday - Tesla  ( NASDAQ:TSLA ) , ALFI  ( NASDAQ:ALF ) ",20221024T154117,https://www.benzinga.com/news/22/10/29381725/stocks-that-hit-52-week-lows-on-monday,BNTC,0.011989,Neutral,0.004433
"Gene therapy market size to grow by USD 4.61 billion from 2022 to 2027, North America is estimated to contribute 39 ... - PR Newswire",20240318T093600,https://www.prnewswire.com/news-releases/gene-therapy-market-size-to-grow-by-usd-4-61-billion-from-2022-to-2027--north-america-is-estimated-to-contribute-39-to-the-growth-technavio-302090363.html,BNTC,0.067064,Somewhat-Bullish,0.179328
Wall Street Analysts See an 113.71% Upside in Benitec Biopharma  ( BNTC ) : Can the Stock Really Move This High?,20241209T145505,https://www.zacks.com/stock/news/2380956/wall-street-analysts-see-an-11371-upside-in-benitec-biopharma-bntc-can-the-stock-really-move-this-high,BNTC,0.287537,Somewhat-Bullish,0.347805
Benitec Biopharma to Participate in Upcoming Investor Conferences in December,20241126T120000,https://www.globenewswire.com/news-release/2024/11/26/2987335/0/en/Benitec-Biopharma-to-Participate-in-Upcoming-Investor-Conferences-in-December.html,BNTC,0.504646,Neutral,-0.138803
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday - Wells Fargo  ( NYSE:WFC ) ,20241014T142936,https://www.benzinga.com/news/24/10/41314267/wells-fargo-to-rally-around-16-here-are-10-top-analyst-forecasts-for-monday,BNTC,0.224903,Somewhat-Bullish,0.306685
Benitec Biopharma Announces Updated Investor Webcast Information,20241014T100000,https://www.globenewswire.com/news-release/2024/10/14/2962404/0/en/Benitec-Biopharma-Announces-Updated-Investor-Webcast-Information.html,BNTC,0.137409,Neutral,-0.054347
Benitec Biopharma Reports Positive Data from Two Subjects Treated with Low-Dose BB-301 in Phase 1b/2a Study Presented at 29th Annual Congress of the World Muscle Society,20241012T103000,https://www.globenewswire.com/news-release/2024/10/12/2962249/0/en/Benitec-Biopharma-Reports-Positive-Data-from-Two-Subjects-Treated-with-Low-Dose-BB-301-in-Phase-1b-2a-Study-Presented-at-29th-Annual-Congress-of-the-World-Muscle-Society.html,BNTC,0.065446,Neutral,-0.012087
Benitec Biopharma Releases Full Year 2024 Financial Results and Provides Operational Update,20240926T203000,https://www.globenewswire.com/news-release/2024/09/26/2954165/0/en/Benitec-Biopharma-Releases-Full-Year-2024-Financial-Results-and-Provides-Operational-Update.html,BNTC,0.062056,Neutral,-0.027164
Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society,20240918T120000,https://www.globenewswire.com/news-release/2024/09/18/2948136/0/en/Benitec-Biopharma-Announces-Late-Breaking-Oral-Abstract-Presentation-on-BB-301-Phase-1b-2a-Clinical-Study-at-the-29th-Annual-Congress-of-the-World-Muscle-Society.html,BNTC,0.126119,Neutral,-0.020547
Benitec Biopharma Announces Late Breaking Oral Abstract Presentation on BB-301 Phase 1b/2a Clinical Study at the 29th Annual Congress of the World Muscle Society - Benitec Biopharma  ( NASDAQ:BNTC ) ,20240918T120000,https://www.benzinga.com/pressreleases/24/09/g40916866/benitec-biopharma-announces-late-breaking-oral-abstract-presentation-on-bb-301-phase-1b2a-clinical,BNTC,0.119433,Neutral,-0.018787
$1M Bet On Biohaven? Check Out These 3 Stocks Insiders Are Buying - Biohaven  ( NYSE:BHVN ) ,20240722T125839,https://www.benzinga.com/trading-ideas/long-ideas/24/07/39883264/1m-bet-on-biohaven-check-out-these-3-stocks-insiders-are-buying,BNTC,0.110462,Neutral,0.0
Benitec Biopharma Reports Continued Durable Improvements in the Radiographic Assessments of Swallowing Efficiency and the Subject-Reported Outcome Instrument at the 180-Day Timepoint for First OPMD Subject Treated with Low-Dose BB-301 in Phase 1b/2a Study,20240715T100000,https://www.globenewswire.com/news-release/2024/07/15/2912881/0/en/Benitec-Biopharma-Reports-Continued-Durable-Improvements-in-the-Radiographic-Assessments-of-Swallowing-Efficiency-and-the-Subject-Reported-Outcome-Instrument-at-the-180-Day-Timepoi.html,BNTC,0.055924,Neutral,-0.010017
Benitec Biopharma Releases Third Quarter 2024 Financial Results and Provides Operational Update,20240513T121500,https://www.globenewswire.com/news-release/2024/05/13/2880424/0/en/Benitec-Biopharma-Releases-Third-Quarter-2024-Financial-Results-and-Provides-Operational-Update.html,BNTC,0.068112,Neutral,-0.027372
Why Is Benitec Biopharma Stock Trading Higher On Thursday? - Benitec Biopharma  ( NASDAQ:BNTC ) ,20240418T170445,https://www.benzinga.com/general/biotech/24/04/38320540/why-is-gene-therapy-developer-benitec-biopharma-stock-trading-higher-on-thursday,BNTC,0.334008,Somewhat-Bullish,0.217298
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study,20240418T113000,https://www.globenewswire.com/news-release/2024/04/18/2865286/0/en/Benitec-Biopharma-Reports-Positive-Interim-Clinical-Trial-Data-for-First-OPMD-Subject-Treated-with-BB-301-in-Phase-1b-2a-Study.html,BNTC,0.084127,Neutral,-0.026186
Benitec Biopharma Reports Positive Interim Clinical Trial Data for First OPMD Subject Treated with BB-301 in Phase 1b/2a Study - Benitec Biopharma  ( NASDAQ:BNTC ) ,20240418T113000,https://www.benzinga.com/pressreleases/24/04/g38310794/benitec-biopharma-reports-positive-interim-clinical-trial-data-for-first-opmd-subject-treated-with,BNTC,0.081276,Neutral,-0.023864
Benitec Biopharma Announces Oversubscribed Private Placement Financing of $40.0 Million,20240418T110000,https://www.globenewswire.com/news-release/2024/04/18/2865234/0/en/Benitec-Biopharma-Announces-Oversubscribed-Private-Placement-Financing-of-40-0-Million.html,BNTC,0.098255,Neutral,0.017429
Benitec Biopharma Announces First Subject Dosed in Phase 1b/2a Clinical Trial for Gene Therapy Candidate BB-301 for the Treatment of Oculopharyngeal Muscular Dystrophy,20231130T120000,https://www.globenewswire.com/news-release/2023/11/30/2788463/0/en/Benitec-Biopharma-Announces-First-Subject-Dosed-in-Phase-1b-2a-Clinical-Trial-for-Gene-Therapy-Candidate-BB-301-for-the-Treatment-of-Oculopharyngeal-Muscular-Dystrophy.html,BNTC,0.105759,Neutral,-0.041136
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference - Benitec Biopharma  ( NASDAQ:BNTC ) ,20231117T130000,https://www.benzinga.com/pressreleases/23/11/g35846777/benitec-biopharma-to-participate-in-a-fireside-chat-at-the-35th-annual-piper-sandler-healthcare-co,BNTC,0.436009,Neutral,-0.105517
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update - Benitec Biopharma  ( NASDAQ:BNTC ) ,20231113T130000,https://www.benzinga.com/pressreleases/23/11/g35746478/benitec-biopharma-releases-first-quarter-2024-financial-results-and-provides-operational-update,BNTC,0.068567,Neutral,-0.026345
"Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket - Axcella Health  ( NASDAQ:AXLA ) , AerSale  ( NASDAQ:ASLE ) ",20230822T123103,https://www.benzinga.com/news/23/08/33981637/why-promis-neurosciences-shares-are-trading-higher-by-33-here-are-20-stocks-moving-premarket,BNTC,0.240489,Somewhat-Bullish,0.162479
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering,20230811T170000,https://www.globenewswire.com/news-release/2023/08/11/2723781/0/en/Benitec-Biopharma-Inc-Announces-Closing-of-30-Million-Underwritten-Public-Offering.html,BNTC,0.146025,Neutral,0.056869
"Dow Edges Higher; Tigo Energy Shares Plunge - Benitec Biopharma  ( NASDAQ:BNTC ) , Decibel Therapeutics  ( NASDAQ:DBTX ) ",20230809T185916,https://www.benzinga.com/news/earnings/23/08/33675981/dow-edges-higher-tigo-energy-shares-plunge,BNTC,0.20698,Somewhat-Bullish,0.191826
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering,20230809T023000,https://www.globenewswire.com/news-release/2023/08/09/2721285/0/en/Benitec-Biopharma-Inc-Announces-Pricing-of-30-Million-Underwritten-Public-Offering.html,BNTC,0.147516,Neutral,0.044252
"Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023",20230725T170000,https://www.globenewswire.com/news-release/2023/07/25/2710757/0/en/Benitec-Biopharma-Announces-1-for-17-Reverse-Stock-Split-Effective-July-26-2023.html,BNTC,0.142989,Neutral,-0.022108
"Benitec Biopharma Announces 1-for-17 Reverse Stock Split Effective July 26, 2023 - Benitec Biopharma  ( NASDAQ:BNTC ) ",20230725T170000,https://www.benzinga.com/pressreleases/23/07/g33374475/benitec-biopharma-announces-1-for-17-reverse-stock-split-effective-july-26-2023,BNTC,0.140076,Neutral,-0.0192
"Dow Surges Over 50 Points; Avalo Therapeutics Shares Plummet - Avalo Therapeutics  ( NASDAQ:AVTX ) , Biomea Fusion  ( NASDAQ:BMEA ) ",20230626T192120,https://www.benzinga.com/news/earnings/23/06/33012823/dow-surges-over-50-points-avalo-therapeutics-shares-plummet,BNTC,0.159569,Somewhat-Bullish,0.200661
"Crude Oil Rises; Carnival Shares Drop After Q2 Results - Avalo Therapeutics  ( NASDAQ:AVTX ) , Biomea Fusion  ( NASDAQ:BMEA ) ",20230626T160901,https://www.benzinga.com/news/earnings/23/06/33009000/crude-oil-rises-carnival-shares-drop-after-q2-results,BNTC,0.143843,Somewhat-Bullish,0.188654
What In The World Is Going On With Benetic Biopharma  ( BNTC )  Stock - Benitec Biopharma  ( NASDAQ:BNTC ) ,20230626T132825,https://www.benzinga.com/news/23/06/33005698/what-in-the-world-is-going-on-with-benetic-biopharma-bntc-stock,BNTC,0.737923,Neutral,0.098543
Benitec Biopharma to Present at the OPMD International Conference,20230508T120500,https://www.globenewswire.com/news-release/2023/05/08/2663267/0/en/Benitec-Biopharma-to-Present-at-the-OPMD-International-Conference.html,BNTC,0.159218,Neutral,-0.053752
RNAi Therapeutics Global Market to 2027: Rising Utilization in Oncology Pharmaceuticals and Accelerating Growth Rates of Infectious Diseases Drives Growth,20230316T184500,https://www.prnewswire.com/news-releases/rnai-therapeutics-global-market-to-2027-rising-utilization-in-oncology-pharmaceuticals-and-accelerating-growth-rates-of-infectious-diseases-drives-growth-301774181.html,BNTC,0.044801,Neutral,0.145391
7 Cheap Robinhood Stocks Under $1 To Watch Trading For Pennies,20230221T210508,https://pennystocks.com/featured/2023/02/21/7-cheap-robinhood-stocks-under-1-to-watch-trading-for-pennies/,BNTC,0.082963,Neutral,0.014372
Benitec Biopharma Enrolls First OPMD Subject into the Clinical Development Program,20230123T144800,https://www.globenewswire.com/news-release/2023/01/23/2593360/0/en/Benitec-Biopharma-Enrolls-First-OPMD-Subject-into-the-Clinical-Development-Program.html,BNTC,0.174587,Neutral,0.125842
"Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs",20221024T113000,https://www.globenewswire.com/news-release/2022/10/24/2539849/0/en/Reunion-Neuroscience-Appoints-Chief-Financial-Officer-and-Vice-President-Medical-Affairs.html,BNTC,0.036812,Neutral,0.02085
"Reunion Neuroscience Appoints Chief Financial Officer and Vice President, Medical Affairs - Reunion Neuroscience  ( NASDAQ:REUN ) ",20221024T113000,https://www.benzinga.com/pressreleases/22/10/g29376187/reunion-neuroscience-appoints-chief-financial-officer-and-vice-president-medical-affairs,BNTC,0.035086,Neutral,0.020685
Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering - Benitec Biopharma  ( NASDAQ:BNTC ) ,20220916T124236,https://www.benzinga.com/pressreleases/22/09/g28895891/benitec-biopharma-inc-announces-closing-of-18-million-underwritten-public-offering,BNTC,0.177584,Neutral,0.05084
Benitec Biopharma Inc. Announces Closing of $18 Million Underwritten Public Offering,20220916T124200,https://www.globenewswire.com/news-release/2022/09/16/2517669/0/en/Benitec-Biopharma-Inc-Announces-Closing-of-18-Million-Underwritten-Public-Offering.html,BNTC,0.183895,Neutral,0.056934
Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering,20220913T020600,https://www.globenewswire.com/news-release/2022/09/13/2514567/0/en/Benitec-Biopharma-Inc-Announces-Pricing-of-18-Million-Underwritten-Public-Offering.html,BNTC,0.171282,Neutral,0.049531
Benitec Biopharma  ( NASDAQ:BNTC )  - Benitec Biopharma Inc. Announces Pricing of $18 Million Underwritten Public Offering,20220913T020600,https://www.benzinga.com/pressreleases/22/09/g28841060/benitec-biopharma-inc-announces-pricing-of-18-million-underwritten-public-offering,BNTC,0.165788,Neutral,0.045452
Benitec Biopharma Releases Full Year 2022 Financial Results and Provides Operational Update,20220902T120000,https://www.globenewswire.com/news-release/2022/09/02/2509215/0/en/Benitec-Biopharma-Releases-Full-Year-2022-Financial-Results-and-Provides-Operational-Update.html,BNTC,0.08609,Neutral,-0.015828
"Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday",20220627T082640,https://www.benzinga.com/news/22/06/27857165/carnival-surges-over-12-heres-75-biggest-movers-from-friday,BNTC,0.091731,Neutral,-0.082587
88 Biggest Movers From Yesterday,20220527T074118,https://www.benzinga.com/news/22/05/27435426/88-biggest-movers-from-yesterday,BNTC,0.066199,Neutral,-0.011095
61 Stocks Moving In Thursday's Mid-Day Session,20220526T161028,https://www.benzinga.com/news/22/05/27423710/61-stocks-moving-in-thursdays-mid-day-session,BNTC,0.064692,Neutral,-0.040638
Benitec Biopharma Releases Q3 2022 Financial Results,20220516T121500,https://www.globenewswire.com/news-release/2022/05/16/2443887/0/en/Benitec-Biopharma-Releases-Q3-2022-Financial-Results.html,BNTC,0.088717,Neutral,0.062785
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors,20220331T122500,https://www.globenewswire.com/news-release/2022/03/31/2413855/0/en/Beroni-Group-Announces-Appointment-of-Dr-John-Chiplin-to-Board-of-Directors.html,BNTC,0.048444,Neutral,0.039627
Beroni Group Announces Appointment of Dr. John Chiplin to Board of Directors,20220331T122500,https://www.benzinga.com/pressreleases/22/03/g26394545/beroni-group-announces-appointment-of-dr-john-chiplin-to-board-of-directors,BNTC,0.046615,Neutral,0.026592
